Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond


If you're shopping for a growth stock to power your portfolio down the road, it's important to choose players that -- even if they're not at the top today -- could become tomorrow's stars. They may be recovering right now or building a platform to bring in billions of dollars in revenue in the years to come. As an investor, you'll want to focus on the particular company's plans for the future and determine if that company has what it takes to reach its goals.

Two candidates with loads of potential are (NASDAQ: MRNA) and Teladoc Health (NYSE: TDOC). Their shares are suffering today, but I see this as a buying opportunity for two stocks that could be unstoppable in the coming years. Let's take a closer look at these two growth players to buy in 2023 and beyond.

Moderna's earnings soared over the past two years thanks to its blockbuster COVID-19 vaccine. And in earlier pandemic days, the stock climbed, too, on optimism about the vaccine, the company's first product. But in recent times, investors have worried about Moderna's post-pandemic days, and as a result, the stock has slipped.

Continue reading


Source Fool.com

Moderna Inc. Aktie

80,88 €
2,65 %
Aufwärts geht es heute für die Moderna Inc. Aktie mit einem Gewinn von 2,65 %.
Und Moderna Inc. steht derzeit mit 21 Buy-Einschätzungen und 2 Sell-Einschätzungen bei unserer Community gut im Kurs.
Eine deutliche Steigerung um mehr als 50% ist für Moderna Inc. mit einem Kursziel von 129 € gegenüber 80.88 € zu erwarten.
Like: 0
Teilen

Kommentare